Calendar PharmaEssentia Corporation

Equities

6446

TW0006446008

End-of-day quote Taiwan S.E. 23:00:00 22/07/2024 BST 5-day change 1st Jan Change
658.00 TWD +5.45% Intraday chart for PharmaEssentia Corporation +7.87% +90.17%

Chart calendar PharmaEssentia Corporation

e8d5b7d876c22258ab39.s6PoWG-huJemMFiJ9IKWAf2XC80MRfS6zksyxZM89RQ.9pacFAXz7vnfRzDArdKkU5bYUoFbP5zMrzFQ_KR6wyfe855vXPff0PQBKw~15ca0da30b7a3113bb01980795673c24

Upcoming events on PharmaEssentia Corporation

07/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
02/03/2025 Q4 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)

Past events on PharmaEssentia Corporation

04/07/2024 June 2024 Sales and Revenue Release
09/06/2024 Goldman Sachs Global Healthcare Conference
06/06/2024 14:00 Jefferies Global Healthcare Conference
05/06/2024 08:51 May 2024 Sales and Revenue Release
30/05/2024 05:00 UBS Asian Investment Conference
27/05/2024 03:00 Annual General Meeting
14/05/2024 First Securities Investor Conference
12/05/2024 Q1 2024 Earnings Release
05/05/2024 07:03 April 2024 Sales and Revenue Release
15/04/2024 QIC Taiwan CEO Week Investor Conference
08/04/2024 09:10 Biotechnology and Medical Care Industry Investor Conference
05/04/2024 03:15 March 2024 Sales and Revenue Release
05/03/2024 08:39 February 2024 Sales and Revenue Release
26/02/2024 06:00 MasterLink Securities Investor Conference
26/02/2024 05:41 Q4 2023 Earnings Release
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number #4575
02/11/2023 21:15 Myeloproliferative Neoplasms International Congress - Abstract Number #116
02/11/2023 21:15 Myeloproliferative Neoplasms International Congress - Abstract Number #137
02/11/2023 21:15 Myeloproliferative Neoplasms International Congress - Abstract Number #133
02/11/2023 21:15 Myeloproliferative Neoplasms International Congress - Abstract Number #141

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million TWD
Released
Forecast
Spread
657
701
-6.3%
2 882
2 882
0%
5 106
5 589
-8.65%

9 284


13 814


19 338

EBITDA
Million TWD
Released
Forecast
Spread
-2 595
-2 509
-3.46%
-1 800
-1 786
-0.8%
-1 645
-1 577
-4.26%

2 064


5 361


6 115

EBIT
Million TWD
Released
Forecast
Spread
-2 822
-2 641
-6.87%
-2 028
-2 012
-0.8%
-1 913
-1 373
-39.33%

1 507


4 410


5 731

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-2 811
-2 700
-4.1%
-1 842
-1 808
-1.87%
-987
-1 446
31.75%

2 315


5 360


6 774

Net income
Million TWD
Released
Forecast
Spread
-2 811
-2 700
-4.1%
-1 375
-1 808
23.96%
-624
-1 418
56.01%

1 972


4 358


5 758

EPS
TWD
Released
Forecast
Spread
-10,8
-10,1
-6.58%
-4,84
-5,98
19.06%
-1,93
-4,72
59.11%

5,94


13,1


17,8

Announcement Date02/03/2201/03/2327/02/24-

Quarterly results

Fiscal PeriodMarch 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million TWD
Released
Forecast
Spread
978
1 196
-18.25%
811
811
-0.02%
842
842
-0.03%
888
930
-4.55%
1 265
1 144
10.56%
1 306
1 716
-23.88%
1 647
2 223
-25.92%
1 653
1 781
-7.16%

2 284


2 608


3 012

EBITDA
Million TWD
Released
Forecast
Spread
-270
-349
22.5%
-511
-471
-8.4%

-309




-349
-546
36.1%
-586
-124
-372.28%

-98,0





551


822


1 003

EBIT
Million TWD
Released
Forecast
Spread
-327
-118
-176.78%
-565
-424
-33.23%
-580
-563
-2.97%
-725
-574
-26.39%
-405
-434
6.62%
-645
-187
-244.94%
-132
-39,0
-238.75%
17,6
3,00
486.17%

378


630


993

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-275
-115
-138.87%
-409
-421
2.89%
-617
-584
-5.73%
-760
-575
-32.18%
-203
-435
53.27%
191
-191
199.93%
-215
-378
43.19%
335
238
40.59%

496


749


1 119

Net income
Million TWD
Released
Forecast
Spread
-275
-115
-138.87%
-409
-421
2.89%
-150
-584
74.25%
-736
-575
-27.92%
-203
-435
53.34%
199
-191
203.94%
116
-378
130.67%
330
230
43.65%

399


602


899

EPS
TWD
Released
Forecast
Spread
-0,98
-0,40
-145%
-1,44
-1,39
-3.6%
-0,47
-1,93
75.65%
-2,44
-1,90
-28.42%
-0,62
-1,40
55.56%
0,66
-0,63
204.76%
0,38
-1,27
129.92%
0,99
0,77
28.57%

1,19


1,79


2,68

Announcement Date12/08/2214/11/2201/03/2311/05/2310/08/2309/11/2327/02/2413/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6446 Stock
  4. Calendar PharmaEssentia Corporation